Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07113951) titled 'Diagnostic Application of AI-ROSE in Severe Pneumonia' on Aug. 3.
Study Type: Observational
Primary Sponsor: The First Affiliated Hospital with Nanjing Medical University
Condition:
Severe Pneumonia
Bacterial Infections
Recruitment Status: Recruiting
Date of First Enrollment: August 31, 2025
Target Sample Size: 100
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07113951
Published by HT Digital Content Services with permission from Health Daily Digest....